$134.00
Manufacturer: Ukraine
Purpose: Dissolves gallstones by reducing cholesterol saturation in bile, treating gallstone disease.
Description
Ursomax (ursodeoxycholic acid) capsules 250 mg. №100
Ingredients
Active ingredient: Ursodeoxycholic acid 250 mg.
Dosage
Dosage: The usual dose is 250 mg to 500 mg daily, taken with food. Consult your healthcare provider for the correct dosage.
Indications
Indications: Ursomax is indicated for the treatment of primary biliary cholangitis, gallstones, and certain liver conditions.
Contraindications
Contraindications: Do not take Ursomax if you are allergic to ursodeoxycholic acid or any other ingredients in the capsules.
Directions
Directions: Swallow the capsules whole with water. Do not crush or chew them. Follow the instructions provided by your healthcare provider.
Scientific Evidence
Ursodeoxycholic acid has been extensively studied for its hepatoprotective effects. Research published in the Journal of Hepatology has shown that ursodeoxycholic acid can improve liver function and reduce liver enzyme levels in patients with primary biliary cholangitis. Additionally, a meta-analysis published in the Cochrane Database of Systematic Reviews demonstrated the efficacy of ursodeoxycholic acid in preventing gallstone formation.
Additional Information
It is important to note that Ursomax may take several weeks to show its full effects. It is crucial to continue taking the medication as prescribed by your healthcare provider, even if you feel better. If you experience any severe side effects or allergic reactions, seek medical attention immediately.
Pharmacological Effects: Ursodeoxycholic acid works by reducing the amount of cholesterol produced by the liver and by dissolving cholesterol in bile, preventing the formation of gallstones. It also has anti-inflammatory and cytoprotective properties, which help protect liver cells from damage.
Clinical Trials: Clinical trials have shown that Ursomax is effective in improving liver function and reducing liver enzyme levels in patients with primary biliary cholangitis. In a randomized controlled trial published in the New England Journal of Medicine, Ursomax was found to significantly decrease serum alkaline phosphatase levels and improve liver histology compared to placebo.
Recent Reviews